Part, Chapter, Paragraph
1 I, 2. 3 | contributing to irregular work remains high. Almost in all Member
2 I, 2. 4 | EU, access to healthcare remains uneven across social groups.
3 I, 2. 5 | contributing to irregular work remains high. Almost in all Member
4 I, 2. 8 | pan-European region is growing and remains dominated by fossil fuels.
5 I, 2. 8 | the energy supply sector remains a major contributor to air
6 I, 2. 8 | installations in all regions remains a key tool to meeting environmental
7 I, 2. 10. 1| data to make sure that it remains up to date, reliable and
8 I, 2. 10. 4| manufacture, which then remains with it throughout the supply
9 I, 3. 1 | later will really top 20% remains to be seen.~ ~Birth cohorts
10 II, 5. 1. 1| and exposure to stress, remains essential in order to reduce
11 II, 5. 1. 1| Finally, rehabilitation remains an important element of
12 II, 5. 1. 1| all CVD risk factors, age remains the most important risk
13 II, 5. 1. 1| macro-areas, lung cancer remains the first cancer diagnosed
14 II, 5. 2. 2| all CVD risk factors, age remains the most important risk
15 II, 5. 2. 3| than in women but still remains the most frequent cause
16 II, 5. 2. 3| more modestly, but still remains the largest single cause
17 II, 5. 3. 4| macro-areas, lung cancer remains the first cancer diagnosed
18 II, 5. 3. 6| for lung cancer patients remains poor, with age-adjusted
19 II, 5. 4. 2| comparable data across countries remains a difficult job, mainly
20 II, 5. 5.Int| countries economic inactivity remains the rule. It is estimated
21 II, 5. 5.Int| depression. Yet depression remains under-recognised and highly
22 II, 5. 5. 3| women and men older than 25 remains low (Hoek and van Hoeken,
23 II, 5. 5. 3| place of living and that it remains stable over time, there
24 II, 5. 5. 3| countries the rate still remains high.~Figure 5.5.3.2.4.
25 II, 5. 5. 3| deal of co-morbid diseases remains undiagnosed and often inadequately
26 II, 5. 14. 2| in the general population remains unclear in many countries.
27 II, 5. 14. 3| and ongoing problem still remains. Minorities and deprived
28 II, 5. 15. 3| identified and 2,160 for which it remains still unknown. According
29 II, 6. 3. 3| 3.2. HIV infection~ ~HIV remains one of the most important
30 II, 6. 3. 3| is slow and the epidemic remains at a low-level.~ ~Much of
31 II, 6. 3. 3| infection. The infection remains concentrated in migrants
32 II, 6. 3. 4| pandemic. However, much remains to be done and it is believed
33 II, 6. 3. 4| SARS-CoV-like viruses. It remains very difficult to predict
34 II, 6. 3. 4| SARS leading to an outbreak remains a distinct possibility,
35 II, 6. 3. 5| where vaccination uptake remains poor.~ ~New vaccines have
36 II, 6. 3. 5| rate from invasive disease remains high (around 8%) and survivors
37 II, 6. 3. 5| imported from endemic countries remains a threat, as demonstrated
38 II, 6. 3. 6| Surveillance of these diseases remains important, not only to discover
39 II, 6. 3. 6| inspection in the EU. The risk remains higher in imported and wild
40 II, 6. 3. 6| 2000. However, uncertainty remains about the possibility of
41 II, 6. 3. 7| to highly endemic areas remains significant.~ ~Viral haemorrhagic
42 II, 9. 2. 2| exercise and the database remains static and undeveloped.
43 II, 9. 2. 2| gathering exercise each remains shelved and not further
44 II, 9. 2. 3| report in 2002, but it still remains unaddressed. Therefore,
45 II, 9. 3. 1| countries economic inactivity remains the norm. It is estimated
46 II, 9. 3. 1| Venous thromboembolism remains a major cause of morbidity
47 II, 9. 3. 1| infection.~Neisseria gonorrhoea remains one of the most common sexually
48 II, 9. 3. 1| mechanism of menopausal flushing remains unclear. Core body temperature
49 II, 9. 3. 1| core temperature elevation remains uncertain.~ ~The physiological
50 II, 9. 3. 1| need for treatment still remains a problem. There is a limited
51 II, 9. 3. 1| understanding of effects, much work remains to be done in terms of research
52 II, 9. 3. 3| intercourse for women still remains close to 20, while for men
53 II, 9. 4. 2| still inadequate. There remains a dearth of data that addresses
54 II, 9. 4. 3| depression; yet, depression remains under-recognised and highly
55 II, 9. 4. 5| Nursing home care. There remains a need for the development
56 II, 9. 4. 5| adjustments to widowhood, this remains one of the leading factors
57 II, 9. 4. 5| the PROCARE programme, it remains possible to identify a number
58 II, 9. 5. 1| that are best for women remains limited. Furthermore, women
59 II, 9. 5. 4| and planning. Much work remains to be done in others. More
60 III, 10. 2. 1| similar and the high level remains constant for a much longer
61 III, 10. 2. 1| public. Furthermore, it remains unclear whether snuff in
62 III, 10. 2. 4| realm of genomics. Also, it remains to be seen whether it will
63 III, 10. 3. 1| effects on health still remains unclear.~ ~This chapter
64 III, 10. 3. 1| high-quality cancer registries remains a high priority.~ ~Electromagnetic
65 III, 10. 3. 1| database for evaluation remains limited, especially for
66 III, 10. 3. 1| the link to ELF fields remains uncertain. No consistent
67 III, 10. 3. 1| of the Montreal Protocol remains a top environmental policy
68 III, 10. 3. 4| although large uncertainty remains in quantifying this burden
69 III, 10. 4. 2| compared to 2004, salmonellosis remains the second most frequently
70 III, 10. 4. 2| ensure that the programme remains up to date and relevant,
71 III, 10. 4. 3| access to safe drinking water remains lower, albeit rising from
72 III, 10. 5. 2| integration initiatives remains unclear.~ ~
73 III, 10. 5. 2| urban versus rural settings remains fuzzy, it is evident that
74 III, 10. 5. 2| EU countries. Still, it remains to be seen to what extent
75 III, 10. 6. 2| EU, access to health care remains uneven across social groups.
76 IV, 11. 1. 1| grounds, the framework itself remains a useful tool for conceptualizing
77 IV, 11. 1. 3| acknowledged that measurement remains difficult. In assessing
78 IV, 11. 1. 5| actual size of medical errors remains difficult.~ ~Not only do
79 IV, 11. 3. 2| by value (2006)~ ~Europe remains the second largest pharmaceutical
80 IV, 11. 5. 4| shortage of organ donors remains the main challenge that
81 IV, 11. 5. 4| indicate that organ trafficking remains on a relatively modest scale
82 IV, 11. 6. 1| rate. Thus, the conflict remains between the demand for and
83 IV, 11. 6. 2| private health insurance remains quite small although it
84 IV, 11. 6. 2| member states its application remains limited by financial, political
85 IV, 11. 6. 2| payment, as the role of PHI remains limited in most countries.
86 IV, 11. 6. 2| these countries, taxation remains an important funding source
87 IV, 11. 6. 2| benefits package (which remains unchanged) and eligibility
88 IV, 11. 6. 2| although in most countries it remains well below 5% of total expenditure.
89 IV, 11. 6. 2| permitting PHI markets, PHI remains relatively undeveloped in
90 IV, 12. 1 | Even today, public health remains mainly a Member State competence.~ ~
91 IV, 12. 10 | sector of the population remains healthy and is provided
92 IV, 13. 5 | This field of research remains underdeveloped and the available
